Abstract
Human synovial sarcomas contain a recurrent and specific chromosomal translocation t(X;18)(p11.2;q11.2). By screening a synovial sarcoma cDNA library with a yeast artificial chromosome spanning the X chromosome breakpoint, we have indentified a hybrid transcript that contains 5′ sequences (designated SYT) mapping to chromosome 18 and 3′ sequences (designated SSX) mapping to chromosome X. An SYT probe detected genomic rearrangements in 10/13 synovial sarcomas. Sequencing of cDNA clones shows that the normal SYT gene encodes a protein rich in glutamine, proline and glycine, and indicates that in synovial sarcoma rearrangement of the SYT gene results in the formation of an SYT–SSX fusion protein. Both SYT and SSX failed to exhibit significant homology to known gene sequences.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Enzinger, F.M. & Weiss, S.W. Soft Tissue Tumours 2nd edn (Mosby, St Louis, 1988).
Smith, S., Reeves, B.R., Wong, L. & Fisher, C. A consistent chromosomal translocation in synovial sarcomas. Cancer Genet. Cytogenet. 26, 179–180 (1987).
Turc-Carel, C. et al. Involvement of chromosome X in primary cytogenetic change in human neoplasia: non random translocation In synovial sarcoma. Proc. natn. Acad. Sci. U.S.A. 84, 1981–1985 (1987).
Wang-Wuu, S., Soukop, S.W. & Lange, B.J. Another synovial sarcoma with t (X;18). Cancer Genet. Cytogenet. 29, 179–181 (1987).
Limon, J. et al. Cytogenetics of synovial sarcoma: Presentation of ten new cases and review of the literature. Genes Chrom. Cancer 3, 338–345 (1991).
Knight, J.C. et al. Cytogenetic and molecular analysis of synovial sarcoma. Int. J. Oncol. 1, 747–752 (1992).
Cooper, C.S. & Stratton, M.R. Soft tissue tumours: the genetic basis of development. Carcinogenesis 12, 155–161 (1991).
Cooper, C.S. The molecular and genetic characterization of human soft tissue tumours. Adv. cancer Res. 60, 75–120 (1993).
Reeves, B.R. et al. Characterization of the translocation between chromosome X and 18 in human synovial sarcoma. Oncogene 4, 373–378 (1989).
Reeves, B.R. et al. Analysis of a specific chromosomal translocation t (X;18) found In human synovial sarcoma. Cancer Cells 7, 69–73 (1989).
Knight, J.C. et al. Localization of the synovial sarcoma t(X;18) (p11.2;q11. 2) breakpoint by fluorescence in situ hybridization. Hum. molec. Genet. 1, 633–637 (1992).
Shipley, J.M. et al. The t(X;18) (p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 9, 1447–1453 (1994).
Yu, H. et al. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76, 933–945 (1994).
Fry, M.J., Panayotou, G., Booker, G.W. & Waterfield, M.D. New insights into protein-tyrosine kinase receptor signalling complexes. Prot. Sci. 2, 1785–1797 (1993).
Lafreniere, R.G., Geraghty, M.T., Valle, D., Shows, T.B. & Willard, H.F. Ornithine amino transferase-related sequences map to two non-adjacent intervals on the human X chromosome short arm. Genomics 10, 276–279 (1991).
Delattre, O. et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162–165 (1992).
Aman, P. et al. Rearrangement of the transcription factor gene CHOP in synovial liposarcoma with t(12;16) (q13;p11). Genes Chrom. Cancer 5, 278–285 (1992).
Rabbitts, T.N., Forster, A., Larson, R. & Nathan, P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet. 4, 175–180 (1993).
Crozat, A., Aman, P., Mandahl, N. & Ron, D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640–644 (1993).
Galili, N. et al. Fusion of a fork head domain gene to PAX in the solid tumour alveolar rhabdomyosarcoma. Nature Genet. 5, 220–235 (1993).
Stroeher, V.L., Jorgensen, E.M. & Garber, R.L. Multiple transcripts from the Antennapedia Gene of Drosophilla melanogaster . Molec. cell. Biol. 6, 4667–4675 (1986).
Mylin, L.M., Gerardot, C.J., Hopper, J.H. & Dickson, R.C. Sequence conservation in the Saccharomyces and Kluveromyces GAL11 transcription activators suggests, functional domains. Nucl. Acids Res. 19, 5345–5350 (1991).
Buettner, R., Yin, S.O., Hong, Y.S., Boncinelli, E. & Tainsky, M.A. Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells. Molec. cell. Biol. 11, 3573–3583 (1991).
Tamkun, J.W. et al. brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SW12. Cell 68, 561–571 (1992).
Sonobe, H. et al. Establishment and characterization of a new human synovial sarcoma cell line HS-SY-II. Lab. Invest. 67, 498–505 (1992).
Fisher, C. Synovial sarcoma. Current Diagnostic Pathology, 1, 13–18 (1994).
Gross, S.J. & Harris, H. New method for mapping genes in human chromosomes. Nature 255, 68–683 (1975).
Mitchell, P.J. & Cooper, C.S. The human tpr gene encodes a protein of 2094 amino acids that has extensive coiled-coil regions and an acidic C-terminal domain. Oncogene 7, 2329–2333 (1992).
Mitchell, P.J. & Cooper, C.S. Nucleotide sequence analysis of human tpr cDNA clones. Oncogene 7, 383–358 (1992).
Feinberg, A.P. & Vogelstein, B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6–13 (1983).
Cooper, C.S. et al. Molecular cloning of a new transforming gene from a chemically-transformed human cell line. Nature 311, 29–33 (1984).
Mikie, T. et al. Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc. natn. Acad. Sci. U.S.A. 88, 5167–5171 (1991).
Snell, R.G. et al. The isolation of cDNAs within the Huntingdon disease region by hybridization of yeast artificial chromosomes to a cDNA library. Hum. molec. Genet. 2, 305–309 (1993).
Sanger, F., Nicklen, S. & Coulsen, A.R. DNA sequencing with chain-terminating inhibitors. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, J., Rocques, P., Crew, A. et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7, 502–508 (1994). https://doi.org/10.1038/ng0894-502
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0894-502
This article is cited by
-
Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability
Nature Structural & Molecular Biology (2023)
-
Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors
Cell Death & Disease (2023)
-
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program
Molecular Cancer (2022)
-
Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
Nature Communications (2022)
-
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Oncogene (2021)